Spotlight
Video

Cabozantinib (XL 184) may be effective according to randomized phase 2 trial results in prostate cancer from the annual meeting in Chicago 2012.

imedex has 1145 videos Subscribe Here

Loading........
Description: Cabozantinib (XL 184) may be effective according to randomized phase 2 trial results in prostate cancer from the annual meeting in Chicago 2012
Shared By : imedex
Posted on : 07/05/12
Added : 5 years ago
Category : Prostate Cancer